Where our technology can help
Transforming Healthcare at the Nanoscale!
Our DNA nanorobots are transforming RNA therapeutics, enabling faster and more precise nucleic acid detection. With Nanovery’s platform, we're accelerating drug development, bringing novel therapies to patients sooner and driving the future of healthcare.
Looking ahead, Nanovery is pioneering a new frontier in diagnostics. Our technology can potentially create a faster, more accessible way to detect diseases, enabling nucleic acid testing anywhere—from labs to point-of-care settings. This vision goes beyond current applications, opening the door to a future where early diagnosis is simple and widespread.
Bioanalysis of ASOs
Antisense oligonucleotides (ASOs) are critical tools in gene therapy, modulating RNA to treat genetic disorders. Our nanorobots enable fast and precise detection of ASOs in complex biological samples, ensuring accurate quantification with minimal preparation.
Bioanalysis of siRNA
Small interfering RNAs (siRNAs) are vital for gene silencing, allowing researchers to selectively shut down disease-causing genes. Nanovery’s nanorobots offer rapid, reliable detection and quantification of siRNAs in plasma and tissue samples, enhancing drug development workflows.
Custom Assay Development
Tailor your research with Nanovery’s custom assays. We collaborate with you to develop high-sensitivity solutions built on our unique DNA nanorobot platform, designed specifically for detecting ASOs and siRNA.
We also target other nucleic acids! Contact us to explore how we can support your specific research needs.
Why choose Nanovery’s NANs technology?
Works directly in complex biological media
Unmatched accuracy in real-world conditions.
Signal amplification at room temperature
Streamlining the analysis process.
Entirely enzyme-free and completely homogenous
Reducing the risk of contamination and error.
Simple and cost-efficient protocol using plate readers
Making advanced testing accessible.
Speak with our Expert
microRNA Biomarkers
Nanovery makes detecting microRNAs simple. Our platform delivers precise, fast results for biomarkers like liver-related microRNAs. No special equipment is needed—just clear, actionable insights.
miRometer-122™ Assay Kit
Coming soon! Nanovery's miRometer-122 Assay Kit will transform liver disease diagnosis with fast, easy detection of miRNA-122. Expect quick, accurate results powered by our patented nanorobot technology.
Interested in the latest clinical data? Contact us to access findings from 150 patient samples, demonstrating the power of our miRometer-122 Assay Kit.